Strategic Considerations for Innovation and Commercialization in the US Biotechnology Sector

References

• Audretsch , D. 2001 . The role of small firms in US biotechnology clusters . Small Business Economics , 17 : 3 – 15 .
   Web of Science ®Google Scholar
• Audretsch , D. and Stephan , P. 1996 . Company-scientist locational links: The case of biotechnology . American Economic Review , 86 : 641 – 653 .
   Web of Science ®Google Scholar
• Audretsch , D. and Stephan , P. 1999 . Knowledge spillovers in biotechnology: Sources and incentives . Journal of Evolutionary Economics , 9 : 97 – 107 .
   Web of Science ®Google Scholar
• Bagchi-Sen , S. , Lawton Smith , H. and Hall , L. 2004 . The US biotechnology industry: Industry dynamics and policy . Environment and Planning C , 22 : 199 – 216 .
   Web of Science ®Google Scholar
• Burrill , G. S. 11 April 2006 . “ A changing prescription for biotechnology. Paper presented at BIO 2006 ” . 11 April , Chicago , IL Available at http://www.burrillandco.com/burrill/pr_1144776165, accessed 22 April 2006.
   Google Scholar
• Casper , S. and Karamanos , A. 2003 . Commercializing science in Europe: The Cambridge biotechnology cluster . European Planning Studies , 11 : 805 – 822 .
   Web of Science ®Google Scholar
• Cooke , P. 2003 . The evolution of biotechnology in three continents: Schumpeterian or Penrosian? . European Planning Studies , 11 : 757 – 763 .
   Web of Science ®Google Scholar
• Cooke , P. 2004 . The molecular biotechnology revolution and the rise of bioscience megacentres in North America and Europe . Environment and Planning C , 22 : 199 – 216 .
   Google Scholar
• Coombs , J. and Deeds , D. 2000 . International alliances as sources of capital: Evidence from the biotechnology industry . Journal of High Technology and Management Research , 11 : 235 – 253 .
   Google Scholar
• Deeds , D. L. and Hill , C. W. L. 1996 . Strategic alliances and the rate of new product development: An empirical study of entrepreneurial biotechnology firms . Journal of Business Venturing , 11 : 41 – 55 .
   Web of Science ®Google Scholar
• Feldman , M. P. and Kelley , M. R. 2002 . How states augment the capabilities of technology-pioneering firms . Growth and Change , 33 : 173 – 195 .
   Web of Science ®Google Scholar
• Feldman , M. P. and Ronzio , C. R. 2001 . Closing the innovative loop: Moving from the laboratory to the shop floor in biotechnology manufacturing . Entrepreneurship and Regional Development , 13 : 1 – 16 .
   Web of Science ®Google Scholar
• Gray , M. 2002 . The micro-level matters . Zeitschrift fur Wirtschaftsgeographie , 46 : 124 – 136 .
   Google Scholar
• Hagedoorn , J. , Link , A. and Vonortas , N. 2000 . Research partnerships . Research Policy , 29 : 567 – 586 .
   Web of Science ®Google Scholar
• Kenney , M. 1998 . “ Biotechnology and the creation of a new economic space ” . In Private Science: Biotechnology and the Rise of the Molecular Sciences , Edited by: Thackray , A. Philadelphia , PA : University of Pennsylvania Press .
   Google Scholar
• Lerner , J. , Shane , H. and Tsai , A. 2003 . Do equity financial cycles matter? Evidence from biotechnology alliances . Journal of Financial Economics , 67 : 411 – 446 .
   Web of Science ®Google Scholar
• Liebeskind , J. P. , Oliver , A. L. , Zucker , L. G. and Brewer , M. B. 1995 . Social Networks, Learning and Flexibility: Sourcing Scientific Knowledge in New Biotechnology Firms , Cambridge , MA : National Bureau of Economic Research . NBER Working Paper Series, No. 5320
   Google Scholar
• Madhok , A. and Osegowitsch , T. 2000 . The international biotechnology industry: Dynamic capabilities perspective . Journal of International Business Studies , 31 : 325 – 336 .
   Web of Science ®Google Scholar
• McCutchen , W. W. Jr and Swamidass , P. M. 1998 . Explaining the differences in domestic and cross-boundary strategic alliances in the pharmaceutical/biotech industry . International Journal of Technology Management , 15 : 490 – 506 .
   Web of Science ®Google Scholar
• McCutchen , W. W. Jr and Swamidass , P. M. 2004 . Motivations for strategic alliances in the pharmaceutical/biotech industry: Some new findings . The Journal of High Technology Management Research , 15 : 197 – 214 .
   Google Scholar
• Pharmaceutical Research and Manufacturers of America (PhRMA) . 2006 . Pharmaceutical Industry Profile 2006 , Washington , DC : PhRMA .
   Google Scholar
• Palmintera , D. 2005 . Accelerating Economic Development through University Technology Transfer , Reston , VA : Innovation Associates Inc . Available at http://www.InnovationAssoc.com
   Google Scholar
• Pisano , G. 1990 . The R&D boundaries of the firm: An empirical analysis . Administrative Sciences Quarterly , 35 : 153 – 176 .
   Web of Science ®Google Scholar
• Pisano , G. 1991 . The governance of innovation: Vertical integration and collaborative arrangements in the biotechnology industry . Research Policy , 20 : 237 – 249 .
   Web of Science ®Google Scholar
• Powell , W. W. 1998 . Learning from collaboration: Knowledge and networks in the biotechnology and pharmaceutical industries . California Management Review , 40 : 228 – 240 .
   Web of Science ®Google Scholar
• Powell , W. W. , Koput , K. W. , Bowie , J. I. and Smith-Doerr , L. 2002 . The spatial clustering of science and capital: Accounting for biotech firm-venture capital relationships . Regional Studies , 36 : 291 – 306 .
   Web of Science ®Google Scholar
• Prevezer , M. 1997 . The dynamics of industrial clustering in biotechnology . Small Business Economics , 9 : 255 – 271 .
   Web of Science ®Google Scholar
• Prevezer , M. 2001 . Ingredients in the early development of the US biotechnology industry . Small Business Economics , 17 : 17 – 29 .
   Web of Science ®Google Scholar
• Rothaermel , F . 2001 . Complimentary assets, strategic alliances, and the incumbent's advantage: An empirical study of industry and firm effects in the biopharmaceutical industry . Research Policy , 30 : 1235 – 1251 .
   Web of Science ®Google Scholar
• Shan , W. and Song , J. 1997 . Foreign direct investment and the sourcing of technological advantage: Evidence from the biotechnology industry . Journal of International Business Studies , 28 : 267 – 284 .
   Web of Science ®Google Scholar
• Zeller , C. 2004 . North Atlantic innovative relations of Swiss pharmaceuticals and the proximities with regional biotech arenas . Economic Geography , 80 : 83 – 111 .
   Web of Science ®Google Scholar
• Zucker , L. G. and Darby , M. R. 1996 . Star Scientists, Institutions, and the Entry of Japanese Biotechnology Enterprises , Cambridge , MA : National Bureau of Economic Research . NBER Working Paper Series, No. 5795
   Google Scholar
• Zucker , L. G. , Darby , M. R. and Brewer , M. B. 1998 . Intellectual human capital and the birth of US biotechnology enterprises . The American Economic Review , 88 : 291 – 306 .
   Google Scholar